Influence of anterior periaortic fat pad excision on incidence of postoperative atrial fibrillation
- PMID: 21470872
- DOI: 10.1016/j.ejcts.2011.02.034
Influence of anterior periaortic fat pad excision on incidence of postoperative atrial fibrillation
Abstract
Objective: In humans, the existence of an anterior periaortic fat pad (AFP) containing parasympathetic ganglia has been described in the aortopulmonary window. Changes in the autonomic nervous system (ANS) tone can lead to postoperative atrial fibrillation (POAF). The AFP is usually removed during coronary bypass grafting (CABG) to fully expose the aortic root. The purpose of this study was to evaluate the influence of AFP removal during CABG on the ANS tone, incidence of POAF, hospital stay, and in-hospital morbidity and mortality.
Methods: A total of 215 patients were randomized in this prospective, double-blind trial to either removal (n=107) or maintenance (n=108) of the AFP during their first CABG. All patients underwent continuous telemetry monitoring after surgery. They underwent at least 1-h Holter monitoring on the second postoperative day. Heart rate variability measurements of both time-domain and frequency-domain analysis were included. POAF was defined as AF for more than 5min or causing hemodynamic instability.
Results: The mean age was nearly 58 years, and 76% were male. There was no difference in the incidence of POAF between the retained and removed AFP groups (19.3% vs 17%, respectively; P=0.664, odds ratio=1.16). Mean heart rate and heart rate variability parameters, in-hospital stay, and postoperative morbidity and mortality were similar in both groups.
Conclusions: Removal of the AFP during CABG has no significant effect on the incidence of POAF, ANS tone, and postoperative morbidity or mortality.
Copyright © 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Impact of epicardial anterior fat pad retention on postcardiothoracic surgery atrial fibrillation incidence: the AFIST-III Study.J Am Coll Cardiol. 2007 Jan 23;49(3):298-303. doi: 10.1016/j.jacc.2006.10.033. Epub 2007 Jan 8. J Am Coll Cardiol. 2007. PMID: 17239710 Clinical Trial.
-
Impact of amiodarone on the ability of anterior fat pad retention to prevent postcoronary arterial bypass grafting atrial fibrillation incidence: a substudy of the AFIST III (Atrial Fibrillation Suppression Trial III).Expert Opin Pharmacother. 2008 Jan;9(1):7-13. doi: 10.1517/14656566.9.1.7. Expert Opin Pharmacother. 2008. PMID: 18076334 Clinical Trial.
-
Usefulness of postoperative atrial fibrillation as an independent predictor for worse early and late outcomes after isolated coronary artery bypass grafting (multicenter Australian study of 19,497 patients).Am J Cardiol. 2012 Jan 15;109(2):219-25. doi: 10.1016/j.amjcard.2011.08.033. Epub 2011 Oct 18. Am J Cardiol. 2012. PMID: 22011556
-
Effect of low-dose amiodarone and magnesium combination on atrial fibrillation after coronary artery surgery.J Card Surg. 2006 Sep-Oct;21(5):458-64. doi: 10.1111/j.1540-8191.2006.00277.x. J Card Surg. 2006. PMID: 16948756 Clinical Trial.
-
Potential use of statins to prevent atrial fibrillation after coronary artery bypass surgery.Ann Pharmacother. 2008 Feb;42(2):253-8. doi: 10.1345/aph.1K590. Epub 2008 Jan 15. Ann Pharmacother. 2008. PMID: 18198239 Review.
Cited by
-
Abnormal heart rate variability and atrial fibrillation after aortic surgery.Rev Bras Cir Cardiovasc. 2015 Jan-Mar;30(1):55-62. doi: 10.5935/1678-9741.20140100. Rev Bras Cir Cardiovasc. 2015. PMID: 25859868 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical